Cite

HARVARD Citation

    Esteban, R. et al. (n.d.). IDDF2019-ABS-0134 Sofosbuvir/velpatasvir is effective and safe in patients with concomitant proton pump inhibitor use in clinical studies. Gut. p. A137. [Online]. 
  
Back to record